I wonder how long the neoadjuvant period last. Interesting, I’m learning lots of new stuff here in the cancer setting.

Quote:

---

Study population will consist of patients with CCR5-positive, locally advanced or metastatic triple-negative breast cancer (mTNBC) who are naïve to chemotherapy in metastatic setting but have been exposed to anthracyclines and taxane in neoadjuvant and adjuvant settings (first-line).

---